The ISPOR 21st Annual International Meeting Issue Panel 20—What Is the Value of Frameworks to Patients? The Case in Oncology—was held this morning in Washington, DC, USA.
The ISPOR 21st Annual International Meeting Issue Panel 18—Precision Medicine: The End of Outcomes Research?—was held this morning in Washington, DC, USA.
The ISPOR 21st Annual International Meeting Workshop 13—Patients as Partners in Research—Making It a Reality—was held this afternoon in Washington, DC, USA.
ISPOR's 21st Annual International Meeting Issue Panel 12—Multi-Criteria Decision Analysis: A New Paradigm in Health Care Decision Making? What Are the Current Status, Challenges, and Opportunities?—was held this afternoon in Washington, DC, USA.
The second ISPOR plenary session on Making Medical Decisions in an Irrational World was held this morning at the Society’s 21st Annual International Meeting in Washington, DC, USA.
ISPOR recognized its 2016 Awards Program recipients at the 21st Annual International Meeting in Washington, DC, USA. The ISPOR Awards Program is designed to foster and recognize excellence and outstanding technical achievement in health economics and outcomes research (HEOR).
ISPOR 21st Annual International Meeting Workshop 2—Risk-Sharing Agreements for Manufacturers and Commercial Payers in the United States: How Can Theory Help Practice? Design and Aligning Incentives Are Key—was held this afternoon in Washington, DC, USA.
ISPOR 21st Annual International Meeting Issue Panel 5—Use of Real-Word Evidence in Payer Decision Making: Fact or Fiction?—was held this morning in Washington, DC, USA.
ISPOR opened its 21st Annual International Meeting this morning with the first plenary session, Accelerating Cures: Addressing Unmet Patient Need or Putting Patients at Risk?, in Washington, DC, USA.
ISPOR announced confirmation of key scientific sessions for its 21st Annual International Meeting starting next week, May 21-25, 2016 in Washington, DC, USA. The meeting will feature three, timely Plenary Sessions centered on the theme, “Value, Affordability, and Patient Centeredness: Can We Have It All?”.
ISPOR announced today that it has published a new Global Health Care Systems Road Map—Australia Medical Devices.
ISPOR announced today that it is expanding its leadership team with the appointment of Richard J. Willke, PhD as Chief Science Officer for the organization.
ISPOR announced today the launch of its new interactive job board, the ISPOR Career Center. With its global focus on health economics and outcomes research (HEOR), the ISPOR Career Center offers job seekers and organizations seeking candidates with HEOR expertise an easy-to-use and highly targeted resource for online employment connections.
ISPOR published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force, ” in the March/April 2016 issue of Value in Health.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced its next Health Technology Assessment (HTA) Training Program will be held in Lisbon, Portugal from 26-29 June 2016.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the recipients of its 2016 Scientific Achievement Awards. The ISPOR Awards Program is designed to foster and recognize excellence and outstanding technical achievement in HEOR.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced its candidates today for open positions on the 2016–2017 Board of Director.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced its three plenary sessions and speakers for the 21st Annual International Meeting that will be held May 21–25, 2016 in Washington, DC, USA. Each of the three plenary sessions will explore the concepts of the conference theme—Value, Affordability, and Patient Centeredness: Can We Have It All?.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force,” in the January/February 2016 issue of Value in Health (Volume 19, Issue 1).
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that its Latin America Consortium Publications Committee has published its first Science Policy Brief—Budget Impact Analysis: New Norms (El Análisis del Impacto Presupuestario: Nuevas Normas).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right